tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Revenue

Compare
104 Followers

Virax Biolabs Group Ltd. Class A Revenue

Virax Biolabs Group Ltd. Class A had a revenue of 79.92K in the quarter ending Mar 31, 2024, with 4.47%. This bring the company's revenue in the last twelve months to 156.42K, Decreased 104.47%. In the fiscal year ending Mar 31, 2024, Virax Biolabs Group Ltd. Class A had annual revenue of 156.42K with ― growth.
Revenue (ttm)
156.42K
Revenue Growth
P/S Ratio
Revenue/Employee
$9,201
Employees
17
Market Cap

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2024156.42K+∞%
Mar 31, 2023
Mar 31, 20220.00-123.82K-100.00%
Mar 31, 2021123.82K23.94K+23.97%
Mar 31, 202099.88K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis